@drprashantmish6 Strong player in the oligopolistic market and can be considered as a proxy play on Pharma &amp; Chemicals capex expansion. 

1) Strong margins, optimizing WCap
2) Significant TAM with &lt;~5% market share in all segments with headroom for growth
3) Tech partnerships &amp; export potential https://t.co/pIDsLeEBaT